Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study

INTRODUCTION: Muscle wasting conditions such as sarcopenia may be highly prevalent in advanced head and neck cancer (HNC) patients (16–71%), with these prevalence rates substantially greater in those who have received chemo-radiotherapy (CRT). According to the updated European Working Group on Sarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Namrata S., Samuel, Stephen Rajan, Meenar, Niranjan, Saxena, PU Prakash, Keogh, Justin W.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049254/
https://www.ncbi.nlm.nih.gov/pubmed/32149024
http://dx.doi.org/10.7717/peerj.8617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049254/
https://www.ncbi.nlm.nih.gov/pubmed/32149024
http://dx.doi.org/10.7717/peerj.8617

Ejemplares similares